iRadimed Q4 Earnings Summary & Key Takeaways
Benzinga Insights 9 months ago
Earnings
iRadimed (NASDAQ:IRMD) announced its Q4 earnings on Tuesday, February 10, 2026 at 07:00 AM.
Here's a breakdown of the earnings report.
Earnings
iRadimed beat estimated earnings by 17.39%, reporting an EPS of $0.54 versus an estimate of $0.46.
Revenue was up $3.30 million from the same period last year.
Historical Earnings Summary
The company beat on EPS by $0.02 in the last quarter, resulting in a 3.12% increase share price change the following day.
Here's a look at iRadimed's past performance:
| Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| EPS Estimate | 0.45 | 0.43 | 0.41 | 0.44 |
| EPS Actual | 0.47 | 0.49 | 0.42 | 0.44 |
| Revenue Estimate | 20.50M | 20.13M | 19.33M | 19.20M |
| Revenue Actual | 21.20M | 20.41M | 19.51M | 19.39M |
To track all earnings releases for iRadimed visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.